Diligence Reporting. COMPANY shall provide M.I.T. with annual reports as described under this Agreement Article 5. In the event that M.I.T. determines that COMPANY (or an AFFILIATE or SUBLICENSEE) has failed to fulfill this obligation, then M.I.T. may treat such failure as a material breach in accordance with Section 12.3(b).
Appears in 2 contracts
Sources: Exclusive Patent License Agreement (Angion Biomedica Corp.), Exclusive Patent License Agreement (Elicio Therapeutics, Inc.)